This strategy resulted in proteins able to bind anti-apoptotic Bcl-2 proteins with increased affinity and specificity, and demonstrated that the designed inhibitors were able to induce apoptosis in cancer cells in vitro by engaging the BH3-binding grooves of specific pro-survival proteins [162]. Here, BCL2 is linked to cancer.